Phathom Pharmaceuticals Statistics

Total Valuation

PHAT has a market cap or net worth of $599.99 million. The enterprise value is $727.46 million.

Market Cap	599.99M
Enterprise Value	727.46M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, before market open.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

PHAT has 58.54 million shares outstanding. The number of shares has increased by 37.82% in one year.

Shares Outstanding	58.54M
Shares Change (YoY)	+37.82%
Shares Change (QoQ)	+1.76%
Owned by Insiders (%)	9.07%
Owned by Institutions (%)	90.61%
Float	45.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	231.30
Forward PS	8.54
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	280.44
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.83

Current Ratio	7.83
Quick Ratio	7.57
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.94

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-77.50%
Return on Capital (ROIC)	-68.14%
Revenue Per Employee	$5,739
Profits Per Employee	-$545,642
Employee Count	452
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.99% in the last 52 weeks. The beta is 0.67, so PHAT's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	-22.99%
50-Day Moving Average	10.28
200-Day Moving Average	9.26
Relative Strength Index (RSI)	45.80
Average Volume (20 Days)	534,084

Short Selling Information

The latest short interest is 13.10 million, so 22.38% of the outstanding shares have been sold short.

Short Interest	13.10M
Short Previous Month	12.33M
Short % of Shares Out	22.38%
Short % of Float	28.51%
Short Ratio (days to cover)	29.16

Income Statement

In the last 12 months, PHAT had revenue of $2.59 million and -$246.63 million in losses. Loss per share was -$4.47.

Revenue	2.59M
Gross Profit	2.00M
Operating Income	-207.19M
Pretax Income	-246.63M
Net Income	-246.63M
EBITDA	-196.07M
EBIT	-196.71M
Loss Per Share	-$4.47

Full Income Statement

Balance Sheet

The company has $325.10 million in cash and $452.57 million in debt, giving a net cash position of -$127.48 million or -$2.18 per share.

Cash & Cash Equivalents	325.10M
Total Debt	452.57M
Net Cash	-127.48M
Net Cash Per Share	-$2.18
Equity (Book Value)	-148.50M
Book Value Per Share	-2.54
Working Capital	296.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$166.93 million and capital expenditures -$1.46 million, giving a free cash flow of -$168.39 million.

Operating Cash Flow	-166.93M
Capital Expenditures	-1.46M
Free Cash Flow	-168.39M
FCF Per Share	-$2.89

Full Cash Flow Statement

Margins

Gross margin is 77.14%, with operating and profit margins of -7,987.24% and -9,507.71%.

Gross Margin	77.14%
Operating Margin	-7,987.24%
Pretax Margin	-9,507.71%
Profit Margin	-9,507.71%
EBITDA Margin	-7,558.52%
EBIT Margin	-7,583.31%
FCF Margin	-6,491.56%

Dividends & Yields

PHAT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.82%
Shareholder Yield	-37.82%
Earnings Yield	-41.11%
FCF Yield	-28.07%

Analyst Forecast

The average price target for PHAT is $22.00, which is 114.63% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.00
Price Target Difference	114.63%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	302.47%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PHAT has an Altman Z-Score of -4.07 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.07
Piotroski F-Score	1